Stroke

NMT Medical Receives FDA Approval For Modifications In Pivotal U.S. PFO/Stroke Trial

Apr 24 2007 - 6:02am

NMT Medical, Inc. has received conditional approval from the U.S. Food and Drug Administration to its revised study hypothesis and statistical plan in the CLOSURE I patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the U.S.

conditions: 

Pages